A Versatile Approach for the Site-Specific Modification of Recombinant Antibodies Using a Combination of Enzyme-Mediated Bioconjugation and Click Chemistry
A unique two‐step modular system for site‐specific antibody modification and conjugation is reported. The first step of this approach uses enzymatic bioconjugation with the transpeptidase Sortase A for incorporation of strained cyclooctyne functional groups. The second step of this modular approach...
Saved in:
Published in: | Angewandte Chemie International Edition Vol. 54; no. 26; pp. 7515 - 7519 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Weinheim
WILEY-VCH Verlag
22-06-2015
WILEY‐VCH Verlag Wiley Subscription Services, Inc |
Edition: | International ed. in English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A unique two‐step modular system for site‐specific antibody modification and conjugation is reported. The first step of this approach uses enzymatic bioconjugation with the transpeptidase Sortase A for incorporation of strained cyclooctyne functional groups. The second step of this modular approach involves the azide–alkyne cycloaddition click reaction. The versatility of the two‐step approach has been exemplified by the selective incorporation of fluorescent dyes and a positron‐emitting copper‐64 radiotracer for fluorescence and positron‐emission tomography imaging of activated platelets, platelet aggregates, and thrombi, respectively. This flexible and versatile approach could be readily adapted to incorporate a large array of tailor‐made functional groups using reliable click chemistry whilst preserving the activity of the antibody or other sensitive biological macromolecules.
A two‐step modular system for site‐specific antibody modification and conjugation is reported. The first step of this approach uses enzymatic bioconjugation with the transpeptidase Sortase A for site‐specific incorporation of strained cyclooctyne functional groups into antibodies. The second step of this modular approach involves the copper‐free azide–alkyne cycloaddition click reaction. |
---|---|
Bibliography: | National Health and Medical Research Council (NHMRC) - No. 1029249; No. 1017670; No. 1011418 ArticleID:ANIE201411507 Victorian Government National Heart Foundation istex:735F69EC111DB315E4E489B97B98F31A5226A259 NHMRC ark:/67375/WNG-Q2STGX0L-B This work was funded by the National Health and Medical Research Council (NHMRC), Grants 1029249, 1017670 and 1011418 as well as the Australian Research Council (P.S.D.). K.Al. is supported by the German Research Foundation (Al 1521/1-1). B.M.P. is supported by a Victorian Postdoctoral Research Fellowship funded by the Victorian Government. K.Ar. is supported by the NHMRC and the National Heart Foundation (586740). P.S.D. is an Australian Research Council Future Fellow. K.P. is a Principal Research Fellow of the NHMRC. C.E.H. is a National Heart Foundation Career Development Fellow. This research was undertaken using equipment provided by Monash Biomedical Imaging, Monash University as part of the Victorian Biomedical Imaging Capability (Victorian Government). The work was also supported in part by the Victorian Government's Operational Infrastructure Support Program, Victoria's Science Agenda Strategic Project Fund, and the PET Solid Target Laboratory, an ANSTO-Austin-LICR Cyclotron Partnership. German Research Foundation - No. Al 1521/1-1 National Heart Foundation - No. 586740 Australian Research Council These authors contributed equally to this work. This work was funded by the National Health and Medical Research Council (NHMRC), Grants 1029249, 1017670 and 1011418 as well as the Australian Research Council (P.S.D.). K.Al. is supported by the German Research Foundation (Al 1521/1‐1). B.M.P. is supported by a Victorian Postdoctoral Research Fellowship funded by the Victorian Government. K.Ar. is supported by the NHMRC and the National Heart Foundation (586740). P.S.D. is an Australian Research Council Future Fellow. K.P. is a Principal Research Fellow of the NHMRC. C.E.H. is a National Heart Foundation Career Development Fellow. This research was undertaken using equipment provided by Monash Biomedical Imaging, Monash University as part of the Victorian Biomedical Imaging Capability (Victorian Government). The work was also supported in part by the Victorian Government’s Operational Infrastructure Support Program, Victoria’s Science Agenda Strategic Project Fund, and the PET Solid Target Laboratory, an ANSTO‐Austin‐LICR Cyclotron Partnership. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.201411507 |